A one-time gene therapy called AMT-130 helped slow the progression of Huntington's disease by 75%, paving the way for the ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to ...

In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with ...

A research team from University College London (UCL) in the UK announced on the 24th of last month, local time, that they ...

The phosphoramidites market shows promising growth in oligonucleotide synthesis, key to gene therapy and personalized ...

Cancer center researchers developed a safer, more targeted gene therapy to kill cancer cells linked to a common herpesvirus — potentially transforming treatment.

The landscape of treating Huntington's disease, a cruel and relentless neurological disorder, may be on the verge of a revolutionary shift. For a disease that has long defied efforts to slow its ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

University of Bristol biotech spin-out company Cirrus Therapeutics has today (Thursday 2 October) announced the close of an ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

The lab-generated eggs could be fertilized with sperm, but were riddled with chromosomal abnormalities. Most embryos stopped ...